Anxiety and Related Sleep Disorders - Norway

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$58.97m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.04%, resulting in a market volume of US$62.09m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$117.20 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Norway is experiencing significant growth and development.

Customer preferences: Customers in Norway are increasingly seeking solutions for anxiety and related sleep disorders. This is driven by a growing awareness and understanding of mental health issues, as well as a desire for improved quality of life. As a result, there is a rising demand for products and services that address these specific needs.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in Norway is the increasing popularity of natural and holistic remedies. Customers are gravitating towards products that are perceived as more natural and have fewer side effects. This trend is driven by a desire for a more holistic approach to health and well-being, as well as a growing preference for sustainable and environmentally-friendly options.Another trend in the market is the rise of digital solutions. Customers are increasingly turning to mobile apps, online platforms, and wearable devices to track and manage their anxiety and sleep disorders. These digital tools provide convenience, accessibility, and real-time monitoring, which are highly valued by customers in Norway.

Local special circumstances: Norway has a high standard of living and a strong focus on health and well-being. The country has a well-developed healthcare system and a culture that values mental health. As a result, there is a supportive environment for the growth of the Anxiety and Related Sleep Disorders market. Additionally, Norway has a high level of digital literacy and internet penetration, making it an ideal market for digital solutions.

Underlying macroeconomic factors: The growth of the Anxiety and Related Sleep Disorders market in Norway is also influenced by underlying macroeconomic factors. Norway has a stable economy with high disposable incomes, which allows customers to invest in their health and well-being. Furthermore, the government in Norway has implemented policies and initiatives to promote mental health and support individuals with anxiety and sleep disorders. This creates a favorable regulatory environment for businesses operating in this market.In conclusion, the Anxiety and Related Sleep Disorders market in Norway is experiencing growth and development due to customer preferences for natural and holistic remedies, the rise of digital solutions, the local special circumstances of a supportive healthcare system and a focus on mental health, and the underlying macroeconomic factors of a stable economy and government support.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.